26.10.2020

Ukkoverkot – Sale of All Shares to Cellnex

Related services

We assisted Ukkoverkot Oy and its shareholders in a transaction in which Cellnex, the leading operator of wireless telecommunications infrastructures in Europe, purchased all the shares in Ukkoverkot Oy, the parent company of EDZCOM, becoming the sole owner of the Edge Connectivity solutions provider.

EDZCOM plans to accelerate its international expansion by entering the UK and French markets at the end of 2020, followed by growth across other European markets in succeeding years, enabled by its new owner, Cellnex.

‘EDZCOM is a growth company with an expert team. Cellnex, with their impressive footprint and capabilities, provides us with access to growth capital and new markets. The complementarity of our businesses promises strong opportunities for vertical integration’, says Mikko Uusitalo, who continues to lead EDZCOM as CEO, in a press release.

EDZCOM is the Nordic market leader in Edge Connectivity – private wireless connectivity solutions.

Cellnex is the main infrastructure operator for wireless telecommunication in Europe, providing services in Italy, the Netherlands, the United Kingdom, France, Switzerland, Ireland, Portugal and Spain.

Our team

Latest references

Oomi – Transfer of KSS Energia’s electricity sales contracts for consumer and business customers to Oomi

We are advising Oomi Oy in a business transaction whereby KSS Energia Oy’s consumer and business customers in the retail sale of electricity will be transferred to Oomi. The transfer is scheduled to take place in March 2025. The arrangement requires approval from the Finnish Competition and Consumer Authority. Oomi Oy is one of the largest energy service companies and electricity sellers in Finland. The arrangement is a result of the recent development of the electricity market and Oomi’s strategy, which aims to offer customers a seamless and improved digital customer experience.

Fortum – Acquisition of a project development portfolio for renewable power from Enersense

We are acting as a counsel to Fortum in a transaction in which Fortum is strengthening its renewable power project pipeline through the acquisition of a project development portfolio from Enersense. The debt-and-cash free purchase price is approximately EUR 9 million, with the potential for project-specific earn-outs subject to projects successfully reaching a final investment decision in the future. The transaction is subject to customary closing conditions and is expected to be completed during the first quarter of 2025. Fortum is a leading Nordic energy company with the purpose to power a world where people, businesses and nature thrive together. Fortum’s core operations comprise of efficient, CO2-free power generation as well as reliable supply of electricity and district heat to private and business customers. The company is listed on Nasdaq Helsinki. One of Fortum’s strategic targets is to develop at least 800 MW of ready-to-build onshore wind and solar projects by the end of 2026.

Hanza AB – Acquisition of Leden Group

We are acting as Finnish advisor to Hanza AB relating to its acquisition of all the shares in Leden Group Oy. Hanza AB is a Swedish mechanical engineering and electronics contract manufacturing company listed on the Stockholm Stock Exchange. Founded in 2008, the company has six manufacturing clusters in Sweden, Finland, Germany, Baltics, Central Europe and China and an annual turnover of approximately SEK 4.6 billion. Leden Group is a leading Finnish contract manufacturer specialising in sheet metal, machining and complex assembly. Leden Group has four production sites in Finland and one in Estonia and an annual turnover of approximately SEK 1.1 billion. The closing of the transaction remains subject to authority approval and customary conditions.

Pharmaca Health Intelligence – Acquisition of PODIUM Connect and PODIUM Visits businesses

We assisted Pharmaca Health Intelligence in its acquisition of Mediaattori Ltd’s PODIUM Connect® and PODIUM Visits businesses. Through the acquisition, Pharmaca Health Intelligence strengthens its extensive service offerings in medical information, data-driven management, and education for both healthcare and pharmaceutical companies. Pharmaca Health Intelligence is a pioneer in digital medical information and a reliable partner for wellbeing services counties, the private healthcare sector and pharmacies. The company invests in the development of technology and service solutions related to pharmaceutical information, also on an international scale.

Search from the site.